GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer

MLA

Chen Chen, et al. “GABRP Promotes CD44s-Mediated Gemcitabine Resistance in Pancreatic Cancer.” PeerJ, vol. 10, July 2022, p. e12728. EBSCOhost, https://doi.org/10.7717/peerj.12728.

APA

Chen Chen, Binfeng Wu, Mingge Wang, Jinghua Chen, Zhaohui Huang, & Jin-Song Shi. (2022). GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. PeerJ, 10, e12728. https://doi.org/10.7717/peerj.12728

Chicago

Chen Chen, Binfeng Wu, Mingge Wang, Jinghua Chen, Zhaohui Huang, and Jin-Song Shi. 2022. “GABRP Promotes CD44s-Mediated Gemcitabine Resistance in Pancreatic Cancer.” PeerJ 10 (July): e12728. doi:10.7717/peerj.12728.